5
podcast episode
Ep. 109: Lessons Learned: the Intersection of Cancer Research and COVID Treatments
“The road to curing COVID runs right through lots and lots of cancer research.” - Jonathan Simons,
President and CEO, Prostate Cancer Foundation
+ Read More
article
Milken Institute Launches “Early Warning” Initiative for Emerging Pandemic Threats as COVID-19 Cases Increase
Washington, D.C. – Dec.
article
New drugs are worth the price; they extend lives and reduce other health-care costs, says economist in latest Milken Institute Review
LOS ANGELES — Are modern drugs worth the price?
Economist Frank R. Lichtenberg answers his own ques
tion with a resounding "yes" in a detailed analysis of "The Value of New Drugs" in the latest issue of The Milken Institute Review.
+ Read More
article
Medicare Drug Price Negotiation Program comment letter
Submitted electronically
Dr. Meena Seshamani
Deputy Administrator and Director, Center for Medicare
Centers for Medicare & Medicaid Services
US Department of Health and Human Services
Baltimore, MD 21244
+ Read More
article
Milken Institute COVID-19 Response
Statement from Milken Institute Chairman Michael Milken
All of us at Milken Institute are working c
losely with leaders in industry, government, and medical research organizations to:
mitigate the spread of COVID-19;
+ Read More